Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-07-31Clinical Trial Update: Intensity-Modulated Radiotherapy for Recurrent Head and Neck Cancer [Phase 2]
A Phase 2 clinical trial evaluating intensity-modulated radiotherapy for recurrent head and neck cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-27Clinical Trial Update: Diagnostic Aids for Detection and Diagnosis of Oral Cancer [Phase 1]
Phase 1 trial evaluating diagnostic aids for detecting and diagnosing oral cancer was withdrawn; no results or outcomes were reported.
-
CLINICAL_TRIALS withdrawal · 2017-04-24Clinical Trial Update: S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors [Phase 1]
The phase 1 S0716 trial of vandetanib in combination with docetaxel for patients with advanced solid tumors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-03-03Clinical Trial Update: Trial to Determine Optimal Phase II Dose of the Oral Dual CAIX Inhibitor/ Radiosensitizer [Phase 1]
The trial to determine the optimal Phase II dose of an oral dual CAIX inhibitor/radiosensitizer for solid tumors, including head and neck ca…
-
CLINICAL_TRIALS withdrawal · 2016-09-21Clinical Trial Update: ROCOCO - Adaptive IMRT Versus IMPT in Head and Neck Cancer
The ROCOCO trial comparing adaptive IMRT versus IMPT for head and neck cancer has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-07-12Clinical Trial Update: Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery [Phase 3]
A Phase 3 trial evaluating docetaxel in combination with St. John's Wort for solid tumors that cannot be removed surgically has been withdra…
-
CLINICAL_TRIALS withdrawal · 2016-06-23Clinical Trial Update: Feeding Tube in Cancer Patients [NA]
A clinical trial evaluating feeding tube use in head and neck cancer patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-05-23Clinical Trial Update: Impact of Nutrition and Swallowing Function of Head and Neck Cancer Patients During the Course of Treatment
A clinical trial (NCT01184027) investigating the impact of nutrition and swallowing function in head and neck cancer patients during treatme…
-
CLINICAL_TRIALS withdrawal · 2016-02-25Clinical Trial Update: Effect of an Oral Supplement on the Total Energy and Protein Intake of Head and Neck Cancer Patients in the Last 2 Weeks of Radiation Therapy [NA]
A head and neck cancer trial evaluating an oral supplement's effect on total energy and protein intake during the last two weeks of radiatio…
-
CLINICAL_TRIALS withdrawal · 2015-10-07Clinical Trial Update: PEctin Rapid Fentanyl Efficacy Clinical Trial For pAin at Swallowing Undergoing radioTherapy [Phase 3]
A Phase 3 trial evaluating rapid fentanyl for breakthrough pain at swallowing in head and neck cancer patients undergoing radiotherapy has b…
-
CLINICAL_TRIALS withdrawal · 2015-10-02Clinical Trial Update: Effects of Swallowing Therapy in Head and Neck Cancer [NA]
The clinical trial evaluating swallowing therapy for head and neck cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-28Clinical Trial Update: Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab [Phase 2]
A Phase 2 trial of selective IMRT with concurrent panitumumab for locally advanced head and neck cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-27Clinical Trial Update: Study Using Pharmacogenetics to Select Treatment for Head and Neck Cancer [Phase 2]
A Phase 2 study using pharmacogenetics to guide treatment for head and neck cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-12-02Clinical Trial Update: A Randomized Comparative Study of a Weekly Versus Every Other Week Nurse Practitioner-led Symptom Management Clinic for Head and Neck Cancer Patients Undergoing Concurrent Chemotherapy and Radiation [NA]
A randomized comparative trial evaluating weekly versus every-other-week nurse practitioner–led symptom management for head and neck cancer …
-
CLINICAL_TRIALS withdrawal · 2014-12-02Clinical Trial Update: A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer [Phase 2]
This document reports the withdrawal of a Phase II trial of proton pump inhibitors in combination with chemotherapy for metastatic head and …
-
CLINICAL_TRIALS withdrawal · 2014-08-19Clinical Trial Update: Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract [NA]
A clinical trial assessing concordance of two endoscopic procedures for diagnosing carcinoma of the upper aerodigestive tract has been withd…
-
CLINICAL_TRIALS withdrawal · 2014-08-06Clinical Trial Update: Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors [Phase 1]
A Phase 1 pharmacokinetic study of porfiromycin in head and neck cancer and other solid-tumor cancer patients has been terminated.
-
CLINICAL_TRIALS withdrawal · 2014-06-17Clinical Trial Update: Insomnia in Patients Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer
A Vanderbilt University-led clinical trial investigating insomnia in patients with head and neck cancer undergoing chemotherapy and radiatio…
-
CLINICAL_TRIALS withdrawal · 2014-01-13Clinical Trial Update: Pilot Study for Locally Advanced Head and Neck Cancer [Phase 2]
A Phase 2 pilot trial for locally advanced head and neck cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-11-05Clinical Trial Update: Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer [Phase 2]
This clinical-trial update reports a Phase 2 study evaluating oxaliplatin and docetaxel for recurrent or metastatic head and neck cancer. Th…
-
CLINICAL_TRIALS withdrawal · 2013-07-10Clinical Trial Update: ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer [Phase 1]
Phase 1 trial of ONYX-015 with cisplatin and fluorouracil for advanced head and neck cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-12-17Clinical Trial Update: A Study of [F-18]HX4 (PET Imaging)Evaluated in Head and Neck Cancer Patients [Phase 1, Phase 2]
An update on the clinical trial evaluating the PET imaging agent [F-18]HX4 in head and neck cancer patients, noting that Phase 1 and Phase 2…
-
CLINICAL_TRIALS withdrawal · 2012-09-07Clinical Trial Update: Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema [NA]
A clinical trial evaluating complete decongestive therapy for head and neck lymphedema has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-09-07Clinical Trial Update: Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy [NA]
A clinical trial evaluating reflux disease in head and neck cancer patients undergoing radiation therapy was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-06-14Clinical Trial Update: S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer [Phase 2]
The SWOG Phase 2 trial S0217 evaluating adjuvant cisplatin and docetaxel after complete resection in Stage III/IV head and neck cancer has b…